Ikena Oncology Inc (IKNA)
1.30
-0.01
(-0.76%)
USD |
NASDAQ |
Apr 26, 16:00
1.29
-0.01
(-0.77%)
After-Hours: 20:00
Ikena Oncology Price to Book Value: 0.3667 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 25, 2024 | 0.3724 |
| April 24, 2024 | 0.3667 |
| April 23, 2024 | 0.3838 |
| April 22, 2024 | 0.3696 |
| April 19, 2024 | 0.3781 |
| April 18, 2024 | 0.3582 |
| April 17, 2024 | 0.3525 |
| April 16, 2024 | 0.361 |
| April 15, 2024 | 0.3639 |
| April 12, 2024 | 0.3781 |
| April 11, 2024 | 0.3923 |
| April 10, 2024 | 0.3582 |
| April 09, 2024 | 0.3781 |
| April 08, 2024 | 0.3752 |
| April 05, 2024 | 0.3838 |
| April 04, 2024 | 0.3866 |
| April 03, 2024 | 0.3795 |
| April 02, 2024 | 0.3795 |
| April 01, 2024 | 0.3951 |
| March 28, 2024 | 0.4037 |
| March 27, 2024 | 0.3951 |
| March 26, 2024 | 0.3951 |
| March 25, 2024 | 0.4094 |
| March 22, 2024 | 0.4207 |
| March 21, 2024 | 0.4264 |
| Date | Value |
|---|---|
| March 20, 2024 | 0.4421 |
| March 19, 2024 | 0.4264 |
| March 18, 2024 | 0.4264 |
| March 15, 2024 | 0.4463 |
| March 14, 2024 | 0.415 |
| March 13, 2024 | 0.4008 |
| March 12, 2024 | 0.3951 |
| March 11, 2024 | 0.415 |
| March 08, 2024 | 0.4548 |
| March 07, 2024 | 0.4463 |
| March 06, 2024 | 0.4492 |
| March 05, 2024 | 0.4179 |
| March 04, 2024 | 0.4179 |
| March 01, 2024 | 0.4179 |
| February 29, 2024 | 0.4065 |
| February 28, 2024 | 0.4293 |
| February 27, 2024 | 0.4293 |
| February 26, 2024 | 0.4321 |
| February 23, 2024 | 0.3781 |
| February 22, 2024 | 0.3781 |
| February 21, 2024 | 0.3781 |
| February 20, 2024 | 0.3951 |
| February 16, 2024 | 0.3895 |
| February 15, 2024 | 0.415 |
| February 14, 2024 | 0.3639 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3525
Minimum
Apr 17 2024
4.449
Maximum
Mar 31 2021
1.366
Average
1.144
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | 1.723 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.6668 |
| Theriva Biologics Inc | 0.1948 |
| Oragenics Inc | 2.986 |
Price to Book Value Related Metrics
| PS Ratio | 5.874 |
| Price | 1.30 |
| Earnings Yield | -126.4% |
| Market Cap | 62.74M |